செரீனா மிகின்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செரீனா மிகின்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செரீனா மிகின்ஸ் Today - Breaking & Trending Today

Fannin Innovation Studio Awarded $2,000,000 NIH Grant for Development of a Novel Antivenom Therapeutic Based on Next-Generation Aptamers

Houston, TX (PRWEB) August 06, 2021 Fannin Innovation Studio announces it has been awarded a $2,000,000 Small Business Innovation Research (SBIR) Phase II ....

United States , Serena Miggins , American Society Of Toxinology , National Natural Toxins Research Center , Raptamer Discovery Group , Texasam University , Small Business Innovation Research , National Institutes Of Health , Space Agency , National Aeronautics , Defense Advanced Research Projects Agency , Office Of Research Infrastructure Programs , Innovation Studio , Business Innovation Research , Research Infrastructure Programs , National Institutes , Atul Varadhachary , Principal Investigator , Managing Partner , Fannin Innovation , North American Society , South America , Southeast Asia , Leo Linbeck , Fannin Innovation Studio , Accelerator Award ,

Allterum Therapeutics completes Series Seed offering, builds team with addition of Philip Breitfeld as Chief Medical Officer

Allterum Therapeutics completes Series Seed offering, builds team with addition of Philip Breitfeld as Chief Medical Officer
News provided by
Share this article
Share this article
HOUSTON, Dec. 17, 2020 /PRNewswire/ Allterum Therapeutics, Inc. completed its $1.8 million Series Seed offering to members of the FanninDirect
SM investor group. Allterum is developing a novel immunotherapy for treatment of IL7R-expressing cancers, including difficult to treat cases of pediatric acute lymphoblastic leukemia (ALL), a program which has received both Orphan Drug and Rare Pediatric Disease Designations from FDA. The company will use the proceeds for its pre-clinical antibody manufacturing and toxicology work and to continue to build the management team. ....

United States , Serena Miggins , Philipp Breitfeld , Product Development , National Cancer Institute , Eric Schafer Baylor College Of Medicine , Therapeutic Centers Of Excellence , Allterum Therapeutics Inc , Cancer Prevention Research Institute Of Texas , Allterum Therapeutics , Series Seed , Orphan Drug , Rare Pediatric Disease Designations , Global Vice President , Therapeutic Centers , Chief Medical , Scott Durum , Atul Varadhachary , Allterum President , Therapeutics Advances , Childhood Leukemia , Eric Schafer , Baylor College , Texas Children , Susan Rheingold , Investigational New Drug ,